These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 16620454)

  • 41. Obsessive-compulsive spectrum disorders: a review of the evidence-based treatments.
    Ravindran AV; da Silva TL; Ravindran LN; Richter MA; Rector NA
    Can J Psychiatry; 2009 May; 54(5):331-43. PubMed ID: 19497165
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Olanzapine-sertraline combination in schizophrenia with obsessive-compulsive disorder.
    Poyurovsky M; Kurs R; Weizman A
    J Clin Psychiatry; 2003 May; 64(5):611. PubMed ID: 12755669
    [No Abstract]   [Full Text] [Related]  

  • 43. Management of obsessive compulsive disorder.
    Bouvard MA; Milliery M; Cottraux J
    Psychother Psychosom; 2004; 73(3):149-57. PubMed ID: 15031587
    [No Abstract]   [Full Text] [Related]  

  • 44. [Cognitive-behavior therapy for obsessive-compulsive disorder: a systematic review of the last decade].
    Prazeres AM; Souza WF; Fontenelle LF
    Braz J Psychiatry; 2007 Sep; 29(3):262-70. PubMed ID: 17713699
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cognitive-behavioral group therapy versus sertraline for obsessive-compulsive disorder: five-year follow-up.
    Borges CP; Meyer E; Ferrão YA; Souza FP; Sousa MB; Cordioli AV
    Psychother Psychosom; 2011; 80(4):249-50. PubMed ID: 21540627
    [No Abstract]   [Full Text] [Related]  

  • 46. Biological approaches to treatment-resistant obsessive compulsive disorder.
    Goodman WK; McDougle CJ; Barr LC; Aronson SC; Price LH
    J Clin Psychiatry; 1993 Jun; 54 Suppl():16-26. PubMed ID: 8331098
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Evidence-based pharmacotherapy and other somatic treatment approaches for obsessive-compulsive disorder: state of the art].
    Kordon A; Zurowski B; Wahl K; Hohagen F
    Nervenarzt; 2011 Mar; 82(3):319-20, 322-4. PubMed ID: 21340636
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effectiveness of olanzapine treatment for severe obsessive-compulsive disorder.
    Marazziti D; Pallanti S
    Am J Psychiatry; 1999 Nov; 156(11):1834-5. PubMed ID: 10553756
    [No Abstract]   [Full Text] [Related]  

  • 49. Olanzapine addition in obsessive-compulsive disorder refractory to selective serotonin reuptake inhibitors: an open-label case series.
    Weiss EL; Potenza MN; McDougle CJ; Epperson CN
    J Clin Psychiatry; 1999 Aug; 60(8):524-7. PubMed ID: 10485634
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clozapine and paroxetine in the treatment of schizophrenia with obsessive-compulsive features.
    Strous RD; Patel JK; Zimmet S; Green AI
    Am J Psychiatry; 1999 Jun; 156(6):973-4. PubMed ID: 10360153
    [No Abstract]   [Full Text] [Related]  

  • 51. When Improving Symptoms Is Not Enough-Is It Time for Next-Generation Interventions for Obsessive-Compulsive Disorder?
    Mataix-Cols D; Fernández de la Cruz L; Rück C
    JAMA Psychiatry; 2020 Jan; 77(1):9-10. PubMed ID: 31509171
    [No Abstract]   [Full Text] [Related]  

  • 52. Combined pharmacotherapy for TS and OCD.
    Hawkridge S; Stein DJ; Bouwer C
    J Am Acad Child Adolesc Psychiatry; 1996 Jun; 35(6):703-4. PubMed ID: 8682749
    [No Abstract]   [Full Text] [Related]  

  • 53. [Personality disorders].
    Kiriike N
    Ryoikibetsu Shokogun Shirizu; 2003; (38):469-72. PubMed ID: 12877028
    [No Abstract]   [Full Text] [Related]  

  • 54. Overcoming treatment resistance in obsessive-compulsive disorder.
    O'Connor K
    Acta Psychiatr Scand; 2005 Apr; 111(4):257-60. PubMed ID: 15740461
    [No Abstract]   [Full Text] [Related]  

  • 55. Cognitive behavior therapy for pediatric obsessive-compulsive disorder.
    Wang Y
    JAMA; 2012 Feb; 307(6):560; author reply 560-1. PubMed ID: 22318271
    [No Abstract]   [Full Text] [Related]  

  • 56. [Combination treatment in children and adolescent with obsessive compulsive disorders].
    Wewetzer C; Walitza S
    MMW Fortschr Med; 2005 Dec; 147(48):36, 38-40. PubMed ID: 16389860
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Obsessive-compulsive disorder. Diagnosis and management.
    Ladouceur R; Freeston M; Gagnon F
    Can Fam Physician; 1996 Jun; 42():1169-72, 1175-8. PubMed ID: 8704492
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Combining Pharmacotherapy with cognitive-behavioral interventions for obsessive-compulsive disorder.
    Cottraux J; Bouvard MA; Milliery M
    Cogn Behav Ther; 2005; 34(3):185-92. PubMed ID: 16201063
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Obsessive compulsive disorder.
    Soomro GM
    Clin Evid; 2002 Dec; (8):991-1002. PubMed ID: 12603924
    [No Abstract]   [Full Text] [Related]  

  • 60. [The mental disorder and obsessive-compulsive spectrum disorders in childhood ].
    Okada T
    Seishin Shinkeigaku Zasshi; 2011; 113(10):992-8. PubMed ID: 22292193
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.